全球動物保健合作協議條款及條件（2017-2026）

全球動物保健產業合作策略標竿

"動物保健合作（2017-2026）" 報告對全球動物保健產業的合作協議進行了全面分析。該報告專為業務拓展、許可和策略專業人士設計，深入剖析了企業如何建立合作關係，以促進獸藥、疫苗、診斷試劑和動物保健技術的研發、商業化和分銷。

這份經過全面修訂和更新的報告分析了自2017年以來發布的280多項動物保健相關協議，清晰地展現了從研發到商業化的企業間合作現狀。這些合作關係通常包含多種要素，從聯合研發開始，逐步發展到授權協議、生產協議和商業化協議。

每份協議記錄都包含可用的財務資訊以及指向詳細線上協議記錄的連結。 如果合約已公開備案，本報告還提供直接存取提交給監管機構的合約文件的途徑，使用戶能夠查看合作夥伴之間協商的詳細條款。

本報告結合詳細的交易數據、財務基準和實際合約文件，為您提供寶貴的見解，幫助您評估動物保健行業的潛在合作夥伴，制定合作協議，並達成更有利的交易。

主要優勢

• 顯著縮短研究時間

您無需搜尋多個資料庫、新聞稿和監管文件，即可存取涵蓋數百個動物製藥合作專案的統一資源。

• 動物製藥交易結構基準分析

了解各公司如何在獸醫和動物保健領域建立合作關係，包括聯合研發協議、許可協議和商業化合作。

• 自信地分析財務條款

審查關鍵合約金額、預付款、里程碑付款和特許權使用費等財務交易條款，並對類似合作關係的價值進行基準評估。

• 查閱實際合約文件

如有條件，請查閱已向美國證券交易委員會 (SEC) 提交的實際合作協議，以深入了解通常不公開的詳細合約條款。

• 辨識動物保健領域最活躍的交易實體

識別在動物保健領域引領合作活動的關鍵公司，並分析其合作策略。

• 追蹤產業合作趨勢

分析自 2017 年以來依技術、治療領域和開發階段劃分的合作活動，以了解動物保健產業的演變。

回報內容

2017年以來獸藥產業合作趨勢分析

獸藥產業交易結構與財務模式概述

基於交易額的主要獸藥合作案例回顧

最活躍的25家獸藥交易撮合者的簡介

依技術類型、治療領域和研發階段分類的交易詳細分析

以字母順序（A-Z）排列的獸藥產業合作綜合名錄

可線上查閱的交易記錄和合約文件連結

基於實際合約的盡職調查見解

本報告分析了實際的合作協議，使用戶能夠評估關鍵的交易條款，例如：內容如下：

• 授權和開發權
• 財務支付結構與里程碑完成條件
• 智慧財產權所有權和許可範圍
• 開發與商業化責任
• 獨家條款與地域權
• 合約期限和終止條款
• 合約文件提供了公司間協商的詳細條款的寶貴資訊。這些資訊很少在新聞稿或傳統交易資料庫中披露。
• 本報告的重要性
• 策略夥伴關係對於動物保健產業的創新至關重要，它使公司能夠整合技術、分擔開發風險並擴大全球商業化能力。
• 本報告透過提供全面的交易數據、財務基準和實際合同，為評估合作機會、建立更牢固的合作關係以及在動物製藥領域更有效地進行談判提供了所需的資訊。

目錄

摘要整理

第一章：引言

第二章：動物保健貿易趨勢

• 引言
• 長期動物保健夥伴關係
• 最活躍的動物保健貿易商
• 依交易類型劃分的動物保健夥伴關係
• 依治療領域劃分的動物保健夥伴關係
• 依技術類型劃分的動物保健夥伴關係
• 動物保健合作夥伴關係的合約條款
  • 動物保健夥伴關係的關鍵價值
  • 動物保健合約的預付款
  • 動物保健交易的里程碑付款
  • 動物保健特許權使用費率

第三章：關鍵動物保健交易

• 引言
• 以價值為排名的頂級獸藥

第四章 - 最活躍的動物保健品交易商

• 引言
• 最活躍的動物保健品交易商
• 最活躍的動物保健品合作夥伴公司簡介

第五章 - 動物保健品合約交易目錄

• 引言
• 動物保健品合約交易目錄

第六章 - 依技術類型劃分的動物保健品交易

附錄

• 附錄 1 - 依公司劃分的獸藥交易 (AZ)
• 附錄 2 - 依研發階段劃分的動物保健品交易
• 附錄 3 - 依交易類型劃分的動物保健品交易
• 附錄 4 -依治療領域劃分的獸醫健康交易
• 附錄 5 - 交易類型定義
• 附錄 6 - 更多信息
• 關於研究公司
• 現有合作夥伴關係
• 現有合約
• 近期合作夥伴發布的報告標題

Benchmark Partnering Strategies Across the Global Animal Health Industry

The Animal Health Partnerships 2017-2026 report provides a comprehensive analysis of partnering agreements across the global animal health sector. Designed for business development, licensing, and strategy professionals, the report delivers detailed insight into how companies structure partnerships to develop, commercialize, and distribute veterinary medicines, vaccines, diagnostics, and animal health technologies.

Fully revised and updated, the report analyzes over 280 animal health agreements announced since 2017, providing a clear view of how companies collaborate across research, development, and commercialization. These partnerships often combine multiple components-beginning with collaborative R&D and progressing through licensing, manufacturing, or commercialization agreements.

Each deal record includes financial information where available and links to detailed online deal records. Where agreements have been publicly filed, the report also provides direct access to contract documents submitted to regulators, enabling users to examine the detailed terms negotiated between partners.

By combining detailed deal data, financial benchmarking, and access to real contract documents, the report provides valuable intelligence for evaluating potential partners, structuring collaboration agreements, and negotiating stronger deals within the animal health industry.

Key Benefits

• Save Significant Research Time

Access a consolidated resource covering hundreds of animal health partnerships rather than searching multiple databases, press releases, and regulatory filings.

• Benchmark Animal Health Deal Structures

Understand how companies structure veterinary and animal health partnerships, including collaborative R&D agreements, licensing arrangements, and commercialization partnerships.

• Analyze Financial Terms with Confidence

Review financial deal terms-including headline values, upfront payments, milestone payments, and royalties-to benchmark the value of comparable partnerships.

• Access Real Contract Documents

Where available, explore actual partnership agreements filed with the SEC, providing insight into detailed contractual provisions that are often not disclosed publicly.

• Identify the Most Active Animal Health Dealmakers

Discover which companies are leading partnering activity across the animal health sector and analyze their collaboration strategies.

• Track Industry Partnering Trends

Analyze partnership activity since 2017 across technologies, therapy areas, and development stages to understand how the animal health industry is evolving.

What's Included in the Report

Analysis of animal health partnering trends since 2017

Overview of animal health deal structures and financial models

Review of the leading animal health partnerships by deal value

Profiles of the top 25 most active animal health dealmakers

Detailed analysis of deals organized by technology type, therapy area, and development stage

A comprehensive directory of animal health partnerships organized by company A-Z

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual partnership contracts, the report enables users to evaluate key deal provisions such as:

• Licensing and development rights
• Financial payment structures and milestone triggers
• Intellectual property ownership and licensing scope
• Development and commercialization responsibilities
• Exclusivity provisions and territorial rights
• Contract duration and termination clauses
• Contract documents provide valuable insight into the detailed terms negotiated between companies-information rarely disclosed in press releases or traditional deal databases.
• Why This Report Matters
• Strategic partnerships are essential to innovation in the animal health industry, allowing companies to combine technologies, share development risk, and expand global commercialization capabilities.
• By providing comprehensive deal data, financial benchmarking, and access to real contract agreements, this report delivers the intelligence needed to evaluate partnership opportunities, structure stronger collaboration agreements, and negotiate more effectively in the animal health sector.

Table of Contents

xecutive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in animal health dealmaking

• 2.1. Introduction
• 2.2. Animal health partnering over the years
• 2.3. Most active animal health dealmakers
• 2.4. Animal health partnering by deal type
• 2.5. Animal health partnering by therapy area
• 2.6. Animal health partnering by technology type
• 2.7. Deal terms for animal health partnering
  • 2.7.1 Animal health partnering headline values
  • 2.7.2 Animal health deal upfront payments
  • 2.7.3 Animal health deal milestone payments
  • 2.7.4 Animal health royalty rates

Chapter 3 - Leading animal health deals

• 3.1. Introduction
• 3.2. Top animal health deals by value

Chapter 4 - Most active animal health dealmakers

• 4.1. Introduction
• 4.2. Most active animal health dealmakers
• 4.3. Most active animal health partnering company profiles

Chapter 5 - Animal health contracts dealmaking directory

• 5.1. Introduction
• 5.2. Animal health contracts dealmaking directory

Chapter 6 - Animal health dealmaking by technology type

Appendices

• Appendix 1 - Animal health deals by company A-Z
• Appendix 2 - Animal health deals by stage of development
• Appendix 3 - Animal health deals by deal type
• Appendix 4 - Animal health deals by therapy area
• Appendix 5 - Deal type definitions
• Appendix 6 - Further reading
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Animal health partnering since 2017
• Figure 2: Active animal health dealmaking activity since 2017
• Figure 3: Animal health partnering by deal type since 2017
• Figure 4: Animal health partnering by disease type since 2017
• Figure 5: Animal health partnering by technology type since 2017
• Figure 6: Animal health deals with a headline value
• Figure 7: Animal health deals with an upfront value
• Figure 8: Animal health deals with a milestone value
• Figure 9: Animal health deals with a royalty rate value
• Figure 10: Top animal health deals by value since 2017
• Figure 11: Most active animal health dealmakers since 2017